Position in BIIB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,348,006,489
+$689,148,863 QoQ
Shares Held
12,807,541
+35.9% QoQ
Ownership
8.68%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 89.63228772798776.ToString("F0")%
Shared 0.ToString("F0")%
None 10.367712272012247.ToString("F0")%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FMR LLC holds $65,159,031,340 across 17 Drug Manufacturers - General names. BIIB ranks #8 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,341,031 | $24,227,690,080 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
71,906,290 | $10,021,579,632 | |
| 3 | JNJ |
Johnson & Johnson
|
24,771,828 | $6,055,225,633 | |
| 4 | AZN |
Astrazeneca PLC
|
29,601,724 | $5,838,052,004 | |
| 5 | MRK |
Merck & Co., Inc.
|
44,516,010 | $5,354,830,840 | |
| 6 | ABBV |
AbbVie Inc.
|
21,762,703 | $4,733,170,273 | |
| 7 | GSK |
GSK plc
|
67,661,646 | $3,734,246,242 | |
| 8 | BIIB |
Biogen Inc.
This page
|
12,807,541 | $2,348,006,489 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,348,006,489 | 12,807,541 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,658,857,626 | 9,425,863 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $180,389,418 | 1,287,760 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $210,265,288 | 1,674,220 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $179,100,022 | 1,308,828 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $115,847,601 | 757,570 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $73,894,518 | 381,214 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $141,506,634 | 610,416 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $133,873,882 | 620,850 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $259,066,029 | 1,001,144 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $349,803,715 | 1,361,051 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $752,152,404 | 2,640,521 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $487,279,268 | 1,752,614 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $335,403,564 | 1,211,193 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $394,153,944 | 1,476,232 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $209,276,292 | 1,026,166 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $81,706,480 | 387,970 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $44,937,254 | 187,301 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $333,235,722 | 1,177,553 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $468,232,525 | 1,352,218 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $535,781,675 | 1,915,216 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $485,280,197 | 1,981,868 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $307,743,439 | 1,084,826 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $305,647,514 | 1,142,394 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $692,187,552 | 2,187,836 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||